Profile data is unavailable for this security.
About the company
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
- Revenue in SEK (TTM)20.12m
- Net income in SEK-18.55m
- Incorporated2007
- Employees6.00
- LocationProstaLund ABScheelevagen 19LUND 223 63SwedenSWE
- Phone+46 46120908
- Websitehttps://www.prostalund.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scandinavian ChemoTech AB | 4.11m | -19.26m | 45.79m | 6.00 | -- | 4.50 | -- | 11.13 | -1.28 | -1.28 | 0.2641 | 0.424 | 0.2327 | 0.3224 | 1.36 | 685,500.00 | -108.95 | -87.29 | -108.95 | -118.55 | 39.00 | 252.05 | -468.27 | -2,122.77 | -- | -15.73 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
Inhalation Sciences Sweden AB | 18.19m | -3.27m | 48.84m | 8.00 | -- | 4.02 | -- | 2.69 | -0.21 | -0.21 | 1.32 | 0.8014 | 1.16 | 0.9413 | 7.49 | 2,273,250.00 | -20.80 | -27.93 | -35.65 | -43.82 | 81.25 | 71.13 | -17.96 | -48.02 | 2.68 | -2.92 | 0.071 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
SciBase Holding AB (publ) | 24.15m | -55.54m | 52.97m | 26.00 | -- | 1.38 | -- | 2.19 | -0.5255 | -0.5255 | 0.2237 | 0.2457 | 0.3004 | 0.7863 | 4.33 | 894,592.60 | -69.07 | -68.63 | -90.03 | -87.77 | 69.28 | 61.28 | -229.94 | -300.20 | 1.78 | -- | 0.00 | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
iZafe Group AB | 5.00m | -32.78m | 59.40m | 7.00 | -- | 2.73 | -- | 11.87 | -0.133 | -0.133 | 0.0201 | 0.0791 | 0.109 | 1.24 | 2.46 | 714,857.10 | -71.38 | -52.17 | -82.09 | -69.40 | -10.99 | -- | -655.02 | -487.50 | 0.6947 | -- | 0.1174 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
ProstaLund AB | 20.12m | -18.55m | 70.50m | 6.00 | -- | 0.8296 | -- | 3.50 | -0.2436 | -0.2436 | 0.2638 | 0.634 | 0.3912 | 0.4325 | 11.14 | -- | -36.07 | -29.14 | -40.73 | -35.01 | 71.05 | 75.26 | -92.21 | -68.94 | 1.90 | -126.96 | 0.0255 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
Glycorex Transplantation AB (publ) | 31.00m | -29.54m | 70.59m | 15.00 | -- | 1.82 | -- | 2.28 | -0.40 | -0.40 | 0.4197 | 0.5485 | 0.3978 | 0.7283 | 4.60 | 1,347,652.00 | -37.91 | -11.30 | -47.48 | -13.17 | 84.79 | 91.60 | -95.30 | -33.24 | 1.20 | -118.90 | 0.2046 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
Kontigo Care AB | 29.47m | 775.00k | 73.71m | 10.00 | 70.10 | 2.06 | 16.22 | 2.50 | 0.0328 | 0.0328 | 1.17 | 1.12 | 0.6807 | -- | 7.69 | -- | 1.79 | -0.4214 | 2.55 | -0.6195 | 68.84 | 66.31 | 2.63 | -0.5205 | -- | 4.00 | 0.093 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
Luxbright AB | 952.90k | -25.38m | 83.92m | 10.00 | -- | 2.49 | -- | 88.06 | -0.2752 | -0.2752 | 0.0103 | 0.3653 | 0.0265 | -- | 1.99 | 95,290.00 | -70.61 | -61.39 | -81.90 | -70.36 | -947.28 | -559.15 | -2,662.94 | -2,459.34 | -- | -1,722.29 | 0.0061 | -- | 73.46 | -- | -20.07 | -- | -- | -- |
BBS-Bioactive Bone Substitutes Oyj | 0.00 | -39.19m | 89.27m | -- | -- | 1.48 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
Scandinavian Real Heart AB | 0.00 | -71.66m | 90.20m | 11.00 | -- | 0.6026 | -- | -- | -0.4709 | -0.4709 | 0.00 | 0.5144 | 0.00 | -- | -- | 0.00 | -67.22 | -24.27 | -78.30 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -701.98 | 0.0945 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
Observe Medical ASA | 27.52m | -59.44m | 93.89m | 12.00 | -- | 0.8247 | -- | 3.41 | -1.05 | -1.05 | 0.4849 | 0.6063 | 0.1191 | 2.49 | 7.12 | 2,328,500.00 | -25.72 | -32.60 | -35.90 | -49.80 | 33.24 | 32.83 | -216.03 | -256.25 | 0.334 | -6.01 | 0.3204 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
Redsense Medical AB (publ) | 19.85m | -7.57m | 102.22m | 5.00 | -- | 5.14 | -- | 5.15 | -0.5389 | -0.5389 | 1.41 | 1.42 | 0.7261 | 4.51 | 5.02 | 3,970,800.00 | -27.67 | -18.66 | -31.75 | -20.99 | 50.11 | 69.02 | -38.11 | -46.28 | 2.21 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
Clinical Laserthermia Systems AB | 10.83m | -70.90m | 104.45m | 7.00 | -- | 1.04 | -- | 9.65 | -14.73 | -14.73 | 1.93 | 5.79 | 0.2173 | 12.58 | 4.86 | -- | -144.45 | -123.49 | -259.50 | -312.95 | -392.44 | -1,084.16 | -664.90 | -1,625.03 | 2.06 | -30.97 | 0.0094 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
Data as of Jun 14 2024. Currency figures normalised to ProstaLund AB's reporting currency: Swedish Krona SEK